サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1231716

アポトーシスの世界市場 2023

Apoptosis
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 72 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アポトーシスの世界市場 2023
出版日: 2023年03月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 72 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

アポトーシスの世界市場は2030年に66億米ドルに達する

変化したCOVID-19後のビジネス環境において、2022年に49億米ドルと推定されるアポトーシスの世界市場は、2022年から2030年にかけてCAGR 3.8％で成長し、2030年までに66億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるアッセイキットは、CAGR3.5%を記録し、分析期間終了時には35億米ドルに達すると予測されます。パンデミック後の回復を考慮し、試薬分野の成長は、今後8年間のCAGRを5.1%に修正しました。

米国市場は14億米ドル、中国はCAGR3.6%で成長すると予測

米国のアポトーシス市場は、2022年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが3.6％となり、2030年までに12億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ3.5％と2.5％の成長が予測されています。欧州では、ドイツがCAGR2.6%で成長すると予測されています。

調査対象企業の例

  • Abcam PLC
  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Biotium, Inc.
  • Creative Bioarray
  • Danaher Corporation
  • GE Healthcare
  • GeneCopoeia, Inc.
  • Geno Technology Inc.
  • Merck KGaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-7636

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Apoptosis Market to Reach $6.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Apoptosis estimated at US$4.9 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at aCAGR of 3.8% over the period 2022-2030. Assay Kits, one of the segments analyzed in the report, is projected to record 3.5% CAGR and reach US$3.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 5.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 3.6% CAGR

The Apoptosis market in the U.S. is estimated at US$1.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 2.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 11 Featured):

  • Abcam PLC
  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Biotium, Inc.
  • Creative Bioarray
  • Danaher Corporation
  • GE Healthcare
  • GeneCopoeia, Inc.
  • Geno Technology Inc.
  • Merck KGaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Apoptosis - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Fluorescence Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Fluorescence Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Fluorescence Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotech Firms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pharmaceutical & Biotech Firms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pharmaceutical & Biotech Firms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospital & Diagnostic Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Hospital & Diagnostic Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Academic & Research Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Academic & Research Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Academic & Research Entities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Apoptosis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • JAPAN
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • CHINA
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • EUROPE
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Apoptosis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Apoptosis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • FRANCE
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • GERMANY
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Apoptosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Apoptosis by End-Use - Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Apoptosis by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Firms, Hospital & Diagnostic Facilities and Academic & Research Entities for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Apoptosis by Product Type - Assay Kits, Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Apoptosis by Product Type - Assay Kits, Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Apoptosis by Product Type - Percentage Breakdown of Value Sales for Assay Kits, Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Apoptosis by By Technique - Flow Cytometry, Fluorescence Microscopy and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Apoptosis by By Technique - Percentage Breakdown of Value Sales for Flow Cytometry, Fluorescence Microscopy and Other Techniques for the Years 2014, 2023 & 2030

IV. COMPETITION